Novo Nordisk (NVO) Total Assets (2014 - 2026)
Novo Nordisk (NVO) total assets from Dec 31, 2014 to Mar 31, 2026. The current Novo Nordisk (NVO) total assets is $86B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Novo Nordisk (NVO) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +62.14% |
| 3 Years TTM | +89.10% |
| 5 Years TTM | +87.97% |
| 10 Years TTM | +20.52% |
| All Time TTM | +20.31% |
Annual Total Assets change of Novo Nordisk (NVO)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $85B | +31.98% |
| 2024 | $65B | +38.89% |
| 2023 | $47B | +34.12% |
| 2022 | $35B | +16.71% |
| 2021 | $30B | +660.52% |
| 2020 | $3.91B | +38.08% |
| 2019 | $2.83B | -83.34% |
| 2018 | $17B | +3.12% |
| 2017 | $16B | +19.46% |
| 2016 | $14B | +3.35% |
| 2015 | $13B | +6.61% |
| 2014 | $13B | N/A |
Comparison Novo Nordisk (NVO) total assets with competitors
Novo Nordisk (NVO) total assets is $86.49B.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| PFE | Pfizer Inc | $207.62B | +140.05% |
| JNJ | Johnson & Johnson | $200.89B | +132.28% |
| ABBV | Abbvie Inc | $136.46B | +57.78% |
| MRK | Merck & Co Inc | $128.69B | +48.79% |
| SNY | Sanofi | $128.02B | +48.02% |
| LLY | Lilly(Eli) & Company | $116.58B | +34.79% |
| AZN | Astrazeneca plc | $114.02B | +31.83% |
| AMGN | AMGEN Inc | $92.50B | +6.95% |
| BMY | Bristol-Myers Squibb Company | $86.48B | -0.02% |
| GSK | GSK Plc | $82.91B | -4.14% |
| GILD | Gilead Sciences Inc | $56.28B | -34.93% |
| BIIB | Biogen Inc | $29.48B | -65.91% |
| GRFS | Grifols SA | $20.10B | -76.76% |
| OGN | Organon & Company | $13.00B | -84.97% |
| AMRN | Amarin Corp | $645.76M | -99.25% |
| SCLX | Scilex Holding Company | $293.63M | -99.66% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | -99.99% |
| MDCX | MDCorp | $7.43M | -99.99% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -99.99% |
| NSRX | Nasus Pharma Ltd | $5.00M | -99.99% |